MEDLINE ANTERIOR HIP, Medline Kit SKU DYNJ909640G Recall
MEDLINE ANTERIOR HIP, Medline Kit SKU DYNJ909640G
FDA recall Class I
Ongoing
FDA lists this Class I recall for MEDLINE ANTERIOR HIP, Medline Kit SKU DYNJ909640G. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2747-2026
- Recall classification
- Class I
- Enforcement status
- Ongoing
- Initiation date
- Jun 5, 2026
- FDA report date
- Jul 29, 2026
- Quantity in commerce
- 60 kits
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
MEDLINE ANTERIOR HIP, Medline Kit SKU DYNJ909640G
Affected model & UDI checker
Search the exact identifiers published for Z-2747-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | MEDLINE ANTERIOR HIP, Medline Kit SKU DYNJ909640G | Check source notice | 10198459280559 |
| Not specified | MEDLINE ANTERIOR HIP, Medline Kit SKU DYNJ909640G | Check source notice | 40198459280550 |
FDA code information
UDI/DI 10198459280559 (each) 40198459280550 (case), Lot Number 25DBF430
Why was this product recalled?
Medline Industries, LP is issuing a recall for specific Medline kits containing B. Braun convenience kits that include Bupivacaine Hydrochloride in Dextrose Injection, USP. B. Braun Medical Inc. was notified by their supplier, Spectra Medical Devices, LLC of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. Huons Co, Ltd. has issued a voluntary recall of this product due to quality issues.
What actions did Medline Industries, LP take?
Medline Industries, LP issued an URGENT MEDICAL DEVICE RECALL notice to its consignees on 6/5/2026 via USPS and email. The notice explained the issue, potential risk to health, and requested the following: identify and quarantine product, and complete response and return the response form using the Website link: https://recalls.medline.com. Those who further distributed the affected product have been directed to notify their customers. Upon receipt of the submitted response form, the consignee will receive over-labels to place on affected inventory, with instructions for your staff to remove and discard the affected component prior to using the kit. These labels will be provided via FedEx overnight, if applicable. For questions, contact the Recall Department at 866-359-1704 or recalls@medline.com.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2747-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology